α-Glucosidase Inhibitor Can Effectively Inhibit the Risk of Tuberculosis in Patients with Diabetes: A Nested Case-Control Study

Diabetes mellitus (DM) and tuberculosis (TB) are major public health and economic burdens. DM increases Mycobacterium tuberculosis (M.tb) infection rates and treatment durations. This study evaluated the relationship between five classes of oral DM medications and TB infection risk in DM patients. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Kai-Huang, Luo, Ci-Wen, Chen, Shih-Pin, Tu, Dom-Gene, Lin, Ming-Shian, Kuan, Yu-Hsiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254087/
https://www.ncbi.nlm.nih.gov/pubmed/32509871
http://dx.doi.org/10.1155/2020/8085106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254087/
https://www.ncbi.nlm.nih.gov/pubmed/32509871
http://dx.doi.org/10.1155/2020/8085106

Ejemplares similares